Literature DB >> 18480625

Histopathologically proven prevention of post-prostatectomy cavernosal fibrosis with sildenafil.

Fabrizio Iacono1, Domenico Prezioso, Pasquale Somma, Stefania Chierchia, Raffaele Galasso, Pietro Micheli.   

Abstract

AIM: To evaluate whether a dose of 50 mg preserved the architecture of the corpora cavernosa biopsy in man.
METHODS: 21 patients (54-70 years old) who underwent radical prostatectomy for prostate cancer were treated with sildenafil citrate (50 mg, 3 times a week for 2 months) soon after surgery. They underwent cavernous biopsy before surgery and after 2 months of sildenafil treatment. Biopsy tissues were fixed in formalin, stained with Masson's trichrome method, and evaluated with the Eureka Interface system with a per-area analysis, and elastic fibers were counted on 10-12 fields (x400) of five serial sections.
RESULTS: Two months after surgery the percent of connective tissue in cavernosa samples in all patients did not differ from that before surgery, being between 30 and 40% in the per-area analysis. Similarly, the elastic fiber count did not differ significantly before and after surgery.
CONCLUSIONS: Sildenafil prevented the progression of fibrosis in prostatectomized patients. Its efficacy seems to result from an antiproliferative effect exerted on fibroblasts. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480625     DOI: 10.1159/000127335

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  10 in total

Review 1.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

2.  [Nerve-sparing radical prostatectomy with nightly low-dose sildenafil : rehabilitation of erectile function].

Authors:  A Bannowsky; H Schulze; C van der Horst; K-P Jünemann
Journal:  Urologe A       Date:  2010-12       Impact factor: 0.639

3.  [Rehabilitation of erectile function after nerve-sparing radical prostatectomy: therapeutic concepts in Germany].

Authors:  A Bannowsky; A Raileanu; S Uckert; H van Ahlen
Journal:  Urologe A       Date:  2013-12       Impact factor: 0.639

4.  Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial.

Authors:  Mikkel Fode; Michael Borre; Dana A Ohl; Jonas Lichtbach; Jens Sønksen
Journal:  BJU Int       Date:  2014-01-22       Impact factor: 5.588

5.  Sonic hedgehog protein is decreased and penile morphology is altered in prostatectomy and diabetic patients.

Authors:  Nicholas L Angeloni; Christopher W Bond; Kevin T McVary; Carol A Podlasek
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.752

Review 6.  Penile rehabilitation after radical prostatectomy: does it work?

Authors:  Giorgio Gandaglia; Nazareno Suardi; Vito Cucchiara; Marco Bianchi; Shahrokh F Shariat; Morgan Roupret; Andrea Salonia; Francesco Montorsi; Alberto Briganti
Journal:  Transl Androl Urol       Date:  2015-04

Review 7.  Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors.

Authors:  Ateş Kadıoğlu; Mazhar Ortaç; Gerald Brock
Journal:  Transl Androl Urol       Date:  2015-04

Review 8.  Does penile rehabilitation have a role in the treatment of erectile dysfunction following radical prostatectomy?

Authors:  Gideon Blecher; Khaled Almekaty; Odunayo Kalejaiye; Suks Minhas
Journal:  F1000Res       Date:  2017-10-31

9.  Antioxidative mechanism of Lycium barbarum polysaccharides promotes repair and regeneration following cavernous nerve injury.

Authors:  Zhan-Kui Zhao; Hong-Lian Yu; Bo Liu; Hui Wang; Qiong Luo; Xie-Gang Ding
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

Review 10.  Urology as rehabilitation medicine: a literature review.

Authors:  Tae Beom Kim; Chang Hee Kim; Kwang Taek Kim; Sang Jin Yoon; Kyung Jin Chung
Journal:  J Exerc Rehabil       Date:  2018-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.